Home
Arranta Bio, LLC

Arranta Bio, LLC Market Share Analysis for February 2026

recipharm is a world leading cdmo. supporting customers in bringing innovations to market, from early stage development to commercial manufacturing.

Industry: N/A

Domainarrantabio.com

Year Founded2019

Employees51 - 200

Annual Revenue$5M - $10M

Arranta Bio, LLC

Arranta Bio, LLC (including company regionals)

arrantabio.com

See more website traffic and engagement information

Arranta Bio, LLC Revenue up to February 2026 is 5M - 10M

revenue generated by Arranta Bio, LLC top domains

Arranta Bio, LLC top domains revenue over 3 years

Revenue for Arranta Bio, LLC top domains

arrantabio.com5M - 10M

See more with Sales Intelligence

Total visits to Arranta Bio, LLC's top domains

Understand Arranta Bio, LLC market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Arranta Bio, LLC's top domains

Analyze Arranta Bio, LLC engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Arranta Bio, LLC's top domains

See how Arranta Bio, LLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Arranta Bio, LLC top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Arranta Bio, LLC

These are the website technologies, by industry, used by Arranta Bio, LLC top domains

Payment & Currencies (8)

Cart Functionality

Widget (5)

Twemoji

Advertising (4)

DoubleClick

Marketing (4)

Google Marketing Platform

More Technologies

9

See all

News & Signals from Arranta Bio, LLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArranta Bio is developing continuous manufacturing technology for mRNA therapeutics."Arranta Bio, part of Recipharm's biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics.

NewsArranta Bio expands facilities to Gainesville, Florida, United States, Northern America, Americas.Arranta is also expanding process development, and GMP capacity at its early-clinical supply facility in Gainesville, FL.